Equity Profile

MASI

Masimo Corporation

Health CareHealth Care Equipment$9.3B

May5Tue

Post-Earnings Recap

ReportedQ1-2026After Close5:10 PM EDT

Masimo Corporation Misses on EPS, Stock Up 0.21%

Metric	Actual	Expected	Surprise
EPS	$1.09	$1.35	-22.70%
Revenue	—	$392M	—

management commentary, guidance changes, and full analysis available with Pro.

Masimo Corporation Misses on EPS, Stock Up 0.21%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$1.09	$1.35	-22.70%
Revenue	—	$392M	—

Management Commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

What It Means

Masimo Corporation reported earnings that fell short of expectations, particularly in EPS, which may raise concerns among investors. Despite the earnings miss, the stock saw a slight increase of 0.21%, indicating some resilience or positive sentiment in the market. The lack of guidance and further commentary from management leaves uncertainty about the company's future performance.

Company Snapshot

Masimo Corporation is a healthcare technology company that develops innovative non-invasive monitoring solutions. With a market cap of $9 billion, it plays a crucial role in improving patient outcomes through advanced medical devices and technologies.

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and helps investors gauge the company's financial health.

$1.35

Revenue

Total revenue reflects the company's ability to generate sales and is vital for assessing growth potential.

$392M

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

-28.73%

Avg Stock Reaction

+1.41%

Last Quarter Recap

In the last quarter, Masimo reported an EPS of -$2.80, significantly missing analyst expectations. The stock saw a slight increase of 0.07% the following day, indicating mixed investor sentiment.

Management Promises & Guidance

Management committed to focusing on product innovation and expanding market reach.
They emphasized the importance of improving operational efficiency.
Plans to enhance customer support and service offerings were also highlighted.

Expectations

Wall Street Expectations

Analysts have set a consensus EPS of $1.35 and revenue of $392 million for this quarter, reflecting cautious optimism after a disappointing previous quarter.

Bull Case

If Masimo can meet or exceed the EPS estimate, it may signal a recovery in profitability and boost investor confidence.

Bear Case

A failure to meet expectations could raise concerns about the company's growth trajectory and operational challenges.

Key Metrics to Watch

EPS

$1.35

Earnings per share is a key indicator of profitability and helps investors gauge the company's financial health.

Revenue

$392M

Total revenue reflects the company's ability to generate sales and is vital for assessing growth potential.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Masimo achieve an EPS of at least $1.35 this quarter?

Meeting this EPS target is crucial for restoring investor confidence after the significant miss last quarter.

What are the revenue growth prospects for Masimo's new product lines?

Insights into revenue growth from new products will indicate the company's ability to innovate and capture market share.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate the impact of recent product innovations, which could drive higher revenue growth than anticipated.

Supporting Evidence

The company has a strong track record of beating EPS estimates, with an 88% success rate over the last eight quarters.

Recent trends in healthcare spending may favor innovative companies like Masimo, potentially boosting demand for their products.

Key Risk

If revenue growth from new products exceeds expectations, it could significantly alter the market's perception of Masimo's growth potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing the potential for recovery against the backdrop of recent disappointing earnings.

Bull Confirmed If

Achieving an EPS of $1.35 or better would confirm the bull case and indicate a strong recovery.

Bear Confirmed If

An EPS below $1.35 would validate concerns about the company's profitability and growth potential.

Pre-Earnings Positioning

Options Market

Implied Move

±2.07%

Historical Avg

±1.8%

Pricing cheap

The options market is pricing in a modest move, suggesting that investors anticipate some volatility around the earnings announcement.

Options are pricing ±0.6% while MASI has averaged ±1.8% over the last 8 prints — setup is pricing cheap.

Detail

30d HV

3.0%

Calls (1K)P/C Ratio: 1.36Puts (800)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Masimo beats expectations, history suggests the stock could rise by about 1.36%, confirming a positive turnaround narrative.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline, with historical patterns indicating a potential drop of around 0.07%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on operational efficiencies and cost management.
3Insights into customer adoption rates of recent technologies.
4Guidance on future revenue growth and market expansion plans.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

May4

GRABReported

Grab Holdings Limited

RecapView

May4

GBDCReported

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and helps investors gauge the company's financial health.

$1.35

Revenue

Total revenue reflects the company's ability to generate sales and is vital for assessing growth potential.

$392M

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

-28.73%

Avg Stock Reaction

+1.41%

Last Quarter Recap

In the last quarter, Masimo reported an EPS of -$2.80, significantly missing analyst expectations. The stock saw a slight increase of 0.07% the following day, indicating mixed investor sentiment.

Management Promises & Guidance

Management committed to focusing on product innovation and expanding market reach.
They emphasized the importance of improving operational efficiency.
Plans to enhance customer support and service offerings were also highlighted.

Expectations

Wall Street Expectations

Analysts have set a consensus EPS of $1.35 and revenue of $392 million for this quarter, reflecting cautious optimism after a disappointing previous quarter.

Bull Case

If Masimo can meet or exceed the EPS estimate, it may signal a recovery in profitability and boost investor confidence.

Bear Case

A failure to meet expectations could raise concerns about the company's growth trajectory and operational challenges.

Key Metrics to Watch

EPS

$1.35

Earnings per share is a key indicator of profitability and helps investors gauge the company's financial health.

Revenue

$392M

Total revenue reflects the company's ability to generate sales and is vital for assessing growth potential.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Masimo achieve an EPS of at least $1.35 this quarter?

Meeting this EPS target is crucial for restoring investor confidence after the significant miss last quarter.

What are the revenue growth prospects for Masimo's new product lines?

Insights into revenue growth from new products will indicate the company's ability to innovate and capture market share.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate the impact of recent product innovations, which could drive higher revenue growth than anticipated.

Supporting Evidence

The company has a strong track record of beating EPS estimates, with an 88% success rate over the last eight quarters.

Recent trends in healthcare spending may favor innovative companies like Masimo, potentially boosting demand for their products.

Key Risk

If revenue growth from new products exceeds expectations, it could significantly alter the market's perception of Masimo's growth potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing the potential for recovery against the backdrop of recent disappointing earnings.

Bull Confirmed If

Achieving an EPS of $1.35 or better would confirm the bull case and indicate a strong recovery.

Bear Confirmed If

An EPS below $1.35 would validate concerns about the company's profitability and growth potential.

Pre-Earnings Positioning

Options Market

Implied Move

±2.07%

Historical Avg

±1.8%

Pricing cheap

The options market is pricing in a modest move, suggesting that investors anticipate some volatility around the earnings announcement.

Options are pricing ±0.6% while MASI has averaged ±1.8% over the last 8 prints — setup is pricing cheap.

Detail

30d HV

3.0%

Calls (1K)P/C Ratio: 1.36Puts (800)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Masimo beats expectations, history suggests the stock could rise by about 1.36%, confirming a positive turnaround narrative.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline, with historical patterns indicating a potential drop of around 0.07%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on operational efficiencies and cost management.
3Insights into customer adoption rates of recent technologies.
4Guidance on future revenue growth and market expansion plans.